Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on September 21, 2026

Sep. 21, 2026

Change to American Depositary Share Ratio

Indeterminate GlobeNewswire

Sep. 21, 2026

HealthLynked Announces Strategic Enterprise Pilot with Palm Beach Accountable Care Organization to Advance AI-Powered Patient Engagement and Value-Based Care

Indeterminate GlobeNewswire

Sep. 21, 2026

Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026

Indeterminate GlobeNewswire

Sep. 21, 2026

Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment

Indeterminate GlobeNewswire

Sep. 21, 2026

InflaRx to Host Virtual Capital Markets Day

Indeterminate GlobeNewswire

Sep. 21, 2026

Dr. Maximilian Doebler appointed Chief Executive Officer of HMNC Brain Health as Company moves into next phase of global growth

Indeterminate GlobeNewswire

Sep. 21, 2026

Seer Announces CFO Transition

Indeterminate GlobeNewswire

Sep. 21, 2026

Vironexis Announces Complete and Durable Responses in Relapsed/Refractory ALL Patients Treated with VNX-101

Indeterminate GlobeNewswire

Sep. 21, 2026

Underarm Pad Surface Area and Handle Angle: The Measurements Behind Crutch Comfort

Indeterminate GlobeNewswire

Sep. 21, 2026

Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day

Indeterminate GlobeNewswire

Sep. 21, 2026

Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab

Indeterminate GlobeNewswire

Sep. 21, 2026

SirPAD Subgroup Study at VIVA 2026 Focuses on Femoropopliteal PAD in Patients With Claudication

Indeterminate GlobeNewswire

Sep. 21, 2026

U.S. Biodefense Rapid Pathogen Identification and Treatments Market to Reach $12.1 Billion by 2031

Indeterminate GlobeNewswire

Sep. 21, 2026

Beacon Therapeutics Reports Positive Topline Data from the Pivotal VISTA Trial of Laru-zova for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

Indeterminate GlobeNewswire

Sep. 21, 2026

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

Indeterminate GlobeNewswire